Paracrine in vivo inhibitory effects of adipose tissue-derived mesenchymal stromal cells in the early stages of the acute inflammatory response

Cytotherapy

Volumn 17, Issue 9, 2015, Pages 1230-1239

  Carceller, María Carmen ^a   Guillén, María Isabel ^a,b   Ferrándiz, María Luisa ^a   Alcaraz, María José ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

Author keywords

Adipose tissue derived stem cells; Conditioned medium; Inflammation; Mouse air pouch

Indexed keywords

CHEMOKINE; CYCLOOXYGENASE 2; CYTOKINE; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOTRIENE B4; MYELOPEROXIDASE; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN; CONDITIONED MEDIUM; IL1B PROTEIN, MOUSE; ISOMERASE; PROSTAGLANDIN E SYNTHASE; RELA PROTEIN, MOUSE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DEGRANULATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; IMMUNOFLUORESCENCE; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE MIGRATION; MALE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIOIMMUNOASSAY; TUMOR NECROSIS FACTOR ESTIMULATED GENE 6; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL MOTION; CONDITIONED MEDIUM; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; LEUKOCYTE; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PHARMACOLOGY; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; CELL MOVEMENT; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTRAMOLECULAR OXIDOREDUCTASES; LEUKOCYTES; LEUKOTRIENE B4; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; PARACRINE COMMUNICATION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 84945966687     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2015.06.001     Document Type: Article

References (41)

1. Prockop D.J. Concise review: two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation. Stem Cells 2013, 31:2042-2046.
2. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.
3. Roddy G.W., Oh J.Y., Lee R.H., Bartosh T.J., Ylostalo J., Coble K., et al. Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-alpha stimulated gene/protein 6. Stem Cells 2011, 29:1572-1579.
4. Ohtaki H., Ylostalo J.H., Foraker J.E., Robinson A.P., Reger R.L., Shioda S., et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A 2008, 105:14638-14643.
5. Lee R.H., Pulin A.A., Seo M.J., Kota D.J., Ylostalo J., Larson B.L., et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5:54-63.
6. Danchuk S., Ylostalo J.H., Hossain F., Sorge R., Ramsey A., Bonvillain R.W., et al. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-alpha-induced protein 6. Stem Cell Res Ther 2011, 2:27.
7. Veronesi F., Maglio M., Tschon M., Aldini N.N., Fini M. Adipose-derived mesenchymal stem cells for cartilage tissue engineering: State-of-the-art in in vivo studies. J Biomed Mater Res A 2014, 102:2448-2466.
8. Leto Barone A.A., Khalifian S., Lee W.P.A., Brandacher G. Immunomodulatory effects of adipose-derived stem cells: fact or fiction?. Biomed Res Int 2013, 2013:383685.
9. Glenn J.D., Whartenby K.A. Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. World J Stem Cells 2014, 6:526-539.
10. Prockop D.J., Oh J.Y. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther 2012, 20:14-20.
11. Platas J., Guillen M.I., del Caz M.D., Gomar F., Mirabet V., Alcaraz M.J. Conditioned media from adipose tissue-derived mesenchymal stem cells down-regulate degradative mediators induced by interleukin-1â in osteoarthritic chondrocytes. Mediators Inflamm 2013, 2013:357014.
12. Sedgwick A.D., Sin Y.M., Edwards J.C., Willoughby D.A. Increased inflammatory reactivity in newly formed lining tissue. J Pathol 1983, 141:483-495.
13. Vicente A.M., Guillen M.I., Alcaraz M.J. Participation of heme oxygenase-1 in a model of acute inflammation. Exp Biol Med 2003, 228:514-516.
14. Moroney M.A., Alcaraz M.J., Forder R.A., Carey F., Hoult J.R.S. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J Pharm Pharmacol 1988, 40:787-792.
15. Paya M., Terencio M.C., Ferrandiz M.L., Alcaraz M.J. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation. Br J Pharmacol 1996, 117:1773-1779.
16. Posadas I., Terencio M.C., Guillén I., Ferrándiz M.L., Coloma J., Payá M., et al. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation. Naunyn-Schmiedeberg's Arch Pharmacol 2000, 361:98-106.
17. Wisniewski H.G., Hua J.C., Poppers D.M., Naime D., Vilcek J., Cronstein B.N. TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo. J Immunol 1996, 156:1609-1615.
18. Getting S.J., Mahoney D.J., Cao T., Rugg M.S., Fries E., Milner C.M., et al. The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan- and inter-alpha -inhibitor-independent manner. J Biol Chem 2002, 277:51068-51076.
19. Viatour P., Merville M.P., Bours V., Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005, 30:43-52.
20. Sadik C.D., Kim N.D., Luster A.D. Neutrophils cascading their way to inflammation. Trends Immunol 2011, 32:452-460.
21. Prokopowicz Z., Marcinkiewicz J., Katz D.R., Chain B.M. Neutrophil myeloperoxidase: soldier and statesman. Arch Immunol Ther Exp (Warsz) 2012, 60:43-54.
22. Klinke A., Nussbaum C., Kubala L., Friedrichs K., Rudolph T.K., Rudolph V., et al. Myeloperoxidase attracts neutrophils by physical forces. Blood 2011, 117:1350-1358.
23. Gouwy M., Struyf S., Noppen S., Schutyser E., Springael J.Y., Parmentier M., et al. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Mol Pharmacol 2008, 74:485-495.
24. Scapini P., Lapinet-Vera J.A., Gasperini S., Calzetti F., Bazzoni F., Cassatella M.A. The neutrophil as a cellular source of chemokines. Immunol Rev 2000, 177:195-203.
25. Soehnlein O., Lindbom L., Weber C. Mechanisms underlying neutrophil-mediated monocyte recruitment. Blood 2009, 114:4613-4623.
26. Matsushima K., Larsen C.G., DuBois G.C., Oppenheim J.J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989, 169:1485-1490.
27. Van Coillie E., Van Damme J., Opdenakker G. The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev 1999, 10:61-86.
28. Alonzi T., Fattori E., Lazzaro D., Costa P., Probert L., Kollias G., et al. Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 1998, 187:461-468.
29. Kyurkchiev D., Bochev I., Ivanova-Todorova E., Mourdjeva M., Oreshkova T., Belemezova K., et al. Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells 2014, 6:552-570.
30. Ivanova-Todorova E., Bochev I., Dimitrov R., Belemezova K., Mourdjeva M., Kyurkchiev S., et al. Conditioned medium from adipose tissue-derived mesenchymal stem cells induces CD4+FOXP3+ cells and increases IL-10 secretion. J Biomed Biotechnol 2012, 2012:295167.
31. Ajuebor M.N., Das A.M., Virag L., Flower R.J., Szabo C., Perretti M. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 1999, 162:1685-1691.
32. Milner C.M., Day A.J. TSG-6: a multifunctional protein associated with inflammation. J Cell Sci 2003, 116:1863-1873.
33. Cao T.V., La M., Getting S.J., Day A.J., Perretti M. Inhibitory effects of TSG-6 Link module on leukocyte-endothelial cell interactions in vitro and in vivo. Microcirculation 2004, 11:615-624.
34. Szanto S., Bardos T., Gal I., Glant T.T., Mikecz K. Enhanced neutrophil extravasation and rapid progression of proteoglycan-induced arthritis in TSG-6-knockout mice. Arthritis & Rheum 2004, 50:312-322.
35. Choi H., Lee R.H., Bazhanov N., Oh J.Y., Prockop D.J. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood 2011, 118:330-338.
36. Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol 2002, 23:144-150.
37. Muzio M., Polentarutti N., Bosisio D., Prahladan M.K., Mantovani A. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J Leukoc Biol 2000, 67:450-456.
38. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-kappaB activity. Annu Rev Immunol 2000, 18:621-663.
39. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004, 25:280-288.
40. Diaz-Munoz M.D., Osma-Garcia I.C., Cacheiro-Llaguno C., Fresno M., Iniguez M.A. Coordinated up-regulation of cyclooxygenase-2 and microsomal prostaglandin E synthase 1 transcription by nuclear factor kappa B and early growth response-1 in macrophages. Cell Signal 2010, 22:1427-1436.
41. Santos R.C., Rico M.A., Bartrons R., Pujol F.V., Rosa J.L., de Oliveira J.R. The transcriptional activation of the cyclooxygenase-2 gene in zymosan-activated macrophages is dependent on NF-kappa B, C/EBP, AP-1, and CRE sites. Inflammation 2011, 34:653-658.